Sign up for the QMED & MD+DI Daily newsletter.
May 18, 2022
2 Min Read
Image courtesy of Jiri Hera / Alamy Stock Photo
There's a reason certain medical devices are never supposed to be used on multiple patients. One medical device manufacturer is in hot water with the feds for allegedly encouraging doctors to reuse its rectal probes and other single-use devices on multiple patients.
The Justice Department has filed a False Claims Act Complaint against The Prometheus Group, a New Hampshire manufacturer of pelvic muscle therapeutic systems and related rectal probes, and the company's president and sole owner, Richard Poore. The reuse of the rectal probes and single-use catheters on multiple patients exposed Medicare beneficiaries to the risks of serious bacterial, fungal, and viral infections, according to the complaint.
“By encouraging the improper reuse of medical devices for financial gain, this manufacturer significantly endangered the health and safety of patients,” said Special Agent in Charge Mario Pinto with the Department of Health and Human Services, Office of the Inspector General (HHS-OIG). “HHS-OIG is committed to working with our law enforcement partners to hold accountable any medical device manufacturers who exploit Federal healthcare programs and threaten the health and safety of beneficiaries.”
Prometheus manufactures and sells device systems for use in pelvic muscle rehabilitation, a non-surgical therapy to eliminate or reduce symptoms of pelvic floor disorders, including urinary and fecal incontinence. Specifically, Prometheus sells the Pathway CTS 2000 Pelvic Floor Training System and the Morpheus System. Both systems required the use of a rectal pressure probe that is inserted into a patient’s rectum during therapy. Prometheus manufactured its own rectal probes for use with the Pathway System and encouraged its customers to use another company’s anorectal manometry catheter with the Morpheus System, according to the complaint.
FDA cleared the Prometheus rectal probe and the anorectal manometry catheter to be used as single-use devices. The instructions for use identify the rectal probe as “a potential bio-hazard” and states that the device is restricted for single person use only. Similarly, the packaging of the anorectal manometry catheter states "do not re-use."
The complaint alleges that the company knew of these restrictions, but "for years encouraged and instructed" healthcare providers to reuse the rectal sensor and anorectal manometry catheters on multiple patients, using a glove or a condom to cover the rectal probes, as a way to reduce the overhead costs associated with the company's technology. The complaint also alleges that the company made no attempt to determine if the devices worked effectively when reused under those conditions.
Attempts to reach Prometheus for comment on this story were unsuccessful. The story will be updated if and when the company responds to MD+DI's request for comment.
About the Author(s)
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read